A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) versus Ranitidine 150mg bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is continued in subjects in the US only

Study identifier:SH-NEN-0005

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

-

Medical condition

NSAID associated Gastric Ulcers

Phase

Phase 3

Healthy volunteers

No

Study drug

Esomeprazole, Ranitidine, Esomeprazole

Sex

All

Actual enrollment

400

Study type

Interventional

Age

18 Years +

Date

Study Start Date: 01 Feb 2001
Primary Completion Date: -
Study Completion Date: 01 Mar 2003

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria